Primary HyperoxaluriaSymptoms, Doctors, Treatments, Advances & More
Learn About Primary Hyperoxaluria
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Pierre Cochat practices practicing medicine in Bron, France. Mr. Cochat is rated as an Elite expert by MediFind in the treatment of Primary Hyperoxaluria. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Primary Hyperoxaluria, Nephrocalcinosis, Primary Hyperoxaluria Type 1, Kidney Transplant, and Liver Transplant.
Bernd Hoppe practices practicing medicine in Bonn, Germany. Mr. Hoppe is rated as an Elite expert by MediFind in the treatment of Primary Hyperoxaluria. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Primary Hyperoxaluria, Nephrocalcinosis, Primary Hyperoxaluria Type 1, Kidney Transplant, and Liver Transplant.
Mayo Clinic-Rochester
Dawn Milliner is a Nephrologist practicing medicine in Virginia Beach, Virginia. Dr. Milliner is rated as an Elite provider by MediFind in the treatment of Primary Hyperoxaluria. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Primary Hyperoxaluria, Primary Hyperoxaluria Type 2, Nephrocalcinosis, Kidney Transplant, and Endoscopy.
Summary: This study will attempt to identify the specific gene (coded in the DNA) and changes (mutations) within that gene that are the cause of monogenic kidney stone disease. This study will help researchers determine the characteristics of the stone disease associated with specific genes and mutations. This information may help develop more effective treatments for monogenic kidney stone diseases.
Summary: The goal of the redePHine study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ABO-101 in participants with primary hyperoxaluria type 1 (PH1). The trial will consist of 2 Study Periods. During the first Study Period, there will be 2 parts. In Part A, adult participants will be treated with a single ascending dose to identify a recommended dose. In Part B, pedia...